Evaluation of inhibitory drug interactions during drug development: Genetic polymorphisms must be considered

被引：25

作者：

Lee, LS ^{[1
]}

Nafziger, AN ^{[1
]}

Bertino, JS ^{[1
]}

机构：

[1] Ordway Res Inst, Clin Pharmacol Studies Unit, Albany, NY 12208 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 78卷 / 01期

关键词：

D O I：

10.1016/j.clpt.2005.04.006

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 6

页数：6

共 36 条

[1] Investigation of terbinafine as a CYP2D6 inhibitor in vivo [J].

Abdel-Rahman, SM ;

Gotschall, RR ;

Kauffman, RE ;

Leeder, JS ;

Kearns, GL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (05) :465-472

[2]

Bachmann Kenneth A, 2002, Am J Ther, V9, P309, DOI 10.1097/00045391-200207000-00008

[3] The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients [J].

Bondolfi, G ;

Eap, CB ;

Bertschy, G ;

Zullino, D ;

Vermeulen, A ;

Baumann, P .

PHARMACOPSYCHIATRY, 2002, 35 (02) :50-56

[4]

Brockmoller J, 2000, Pharmacogenomics, V1, P125, DOI 10.1517/14622416.1.2.125

[5] Genetic determinants of drug responsiveness and drug interactions [J].

Caraco, Y .

THERAPEUTIC DRUG MONITORING, 1998, 20 (05) :517-524

[6] Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19 [J].

Cho, JY ;

Yu, KS ;

Jang, IJ ;

Yang, BH ;

Shin, SG ;

Yim, DS .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (04) :393-397

[7] Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans [J].

Eap, CB ;

Lessard, E ;

Baumann, P ;

Brawand-Amey, M ;

Yessine, MA ;

O'Hara, G ;

Turgeon, J .

PHARMACOGENETICS, 2003, 13 (01) :39-47

[8] Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans [J].

Furuta, T ;

Ohashi, K ;

Kobayashi, K ;

Iida, I ;

Yoshida, H ;

Shirai, N ;

Takashima, M ;

Kosuge, K ;

Hanai, H ;

Chiba, K ;

Ishizaki, T ;

Kaneko, E .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (03) :265-274

[9] Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity [J].

Hamelin, BA ;

Bouayad, A ;

Méthot, J ;

Jobin, J ;

Desgagnés, P ;

Poirier, P ;

Allaire, J ;

Dumesnil, J ;

Turgeon, J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (05) :466-477

[10]

HANSTEN PD, 2000, METABOLIC DRUG INTER, P715

← 1 2 3 4 →